ATAI Life Sciences(ATAI) - 2024 Q2 - Quarterly Results

Exhibit 99.1 atai Life Sciences Reports Second Quarter 2024 Financial Results and Provides Corporate Updates - Reported positive Phase 1b results of VLS-01 (buccal film DMT); expect to initiate a Phase 2 study in treatment-resistant depression patients around YE'24 - Announced clinical development plans for EMP-01 (oral R-MDMA); expect to initiate a Phase 2 study of EMP-01 in social anxiety disorder patients around YE'24 - Cash, marketable securities, and committed term loan funding expected to fund operati ...